CRISPR patent ruling leaves license holders scrambling.
Science (New York, N.Y.), 355(6327): 786 PMID 28232532 DOI 10.1126/science.355.6327.786
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.